IBB

Recent Articles

The 4 Biggest Stories to Watch in Q2

If you have money in this market, then you need to tune your radar to the circumstances over the next three months influencing your money. More 

S&P 500, Nasdaq Take a Licking as Economic Doubts Grow

Biotechs, semiconductors and financials among the worst-hit stocks in Wednesday's economic data-driven selloff. More 

Is Biotech too “Frothy”?

We can look for common issues that have appeared in the past before significant corrections, and from that perspective, biotechnology looks overheated. More 

Are Large-Cap Biotech Stocks in a Bubble?

Biotech stocks have outpaced the rest of the market by a huge margin, but it takes more than gaudy performance numbers to create a bubble. More 

5 Biotech ETFs to Buy for Evolving Growth

The biotechnology story is one that continues to highlight evolving growth opportunities in the medical field. More 

IBB: The Biotech Stock Boom Rolls On

Biotech stocks continue to defy gravity. Profit from their ascendance with options on the IBB ETF. More 

Biotech, Blue-Chip Tech Buckle as Nasdaq Cedes 5K

Microsoft (MSFT), Micron (MU) and biotechs (IBB) took a slide in Tuesday trading. Investors should continue to exercise caution at these highs. More